RESEARCH-USE BIOSIMILAR ANTIBODY

Cobolimab

Monoclonal antibody · IgG4

HAVCR2IgG4RUO

Cobolimab (TSR-022) is an anti-TIM-3 monoclonal antibody. Cobolimab mediates the internalization of TIM3 with an IC50 value of 0.4464 nM. Cobolimab has potential application in solid tumors and non-small cell lung cancer (NSCLC).

TARGETHAVCR2
YMonoclonal antibody
CATALOGSC-BS-663
CATALOG NUMBERSC-BS-663
MOLECULAR WEIGHTApprox. 142.84 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Cobolimab (TSR-022) is an anti-TIM-3 monoclonal antibody. Cobolimab mediates the internalization of TIM3 with an IC50 value of 0.4464 nM. Cobolimab has potential application in solid tumors and non-small cell lung cancer (NSCLC).

Cobolimab is a recombinant research-use antibody directed against HAVCR2.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte